Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2000
11/08/2000EP1049466A2 Carbonic anhydrase inhibitor for increasing oxygen tension in the optic nerve and retina
11/08/2000EP1049441A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
11/08/2000EP0734396B1 ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/08/2000CN1272784A Medicinal compositions for application to mucosa
11/08/2000CN1272370A Eye ointment for curing myopia and its production process
11/07/2000US6143886 Azepinone compounds useful in the inhibition of ACE and NEP
11/07/2000US6143783 Amino acids
11/07/2000US6143746 Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
11/07/2000US6143521 Human bombesin receptor subtype-3sb
11/07/2000CA2170485C Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
11/07/2000CA2080223C Thiophene sulfonamides useful as carbonic anhydrase inhibitors
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000065028A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
11/02/2000WO2000064946A2 Compositions and methods for cancer treatment by selectively inhibiting vegf
11/02/2000WO2000064932A1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
11/02/2000WO2000064887A1 Renin inhibitors
11/02/2000WO2000064873A1 Renin inhibitors
11/02/2000WO2000064859A1 Amide derivatives
11/02/2000WO2000064474A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
11/02/2000WO2000064467A1 Inhibition of proteasome function induces programmed cell death in endothelial cells
11/02/2000WO2000064449A1 Thrombin inhibitors
11/02/2000WO2000064429A1 Pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and protozoa
11/02/2000WO2000064425A2 Miotic agents and hypertonic agents containing ophthalmic compositions
11/02/2000WO2000064420A2 Compositions and methods for treating amyloidosis using sulphonate derivatives
11/02/2000WO2000040714A3 Therapeutic phosphodiesterase inhibitors
11/02/2000WO2000039299A3 Streptococcus antigens
11/02/2000WO2000039083A3 Pyrazole compounds and uses thereof
11/02/2000EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses
11/02/2000EP1048657A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
11/02/2000EP1047776A2 Therapeutic composition comprising the kal protein and use of the kal protein
11/02/2000EP1047447A1 LIPOOLIGOSACCHARIDE-BASED VACCINE FOR PREVENTION OF $i(MORAXELLA) $i((BRANHAMELLA)) $i(CATARRHALIS) INFECTIONS IN MAMMALS
11/02/2000EP1047434A2 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
11/02/2000EP1047429A1 The use of brinzolamide to prevent visual field loss
11/02/2000EP1047425A1 Integrin receptor antagonists
11/02/2000EP1047416A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis
11/02/2000EP1047410A1 Treatment of glc1a glaucoma with non-steroidal glucocorticoid antagonists
11/02/2000EP1047406A1 Autoclavable pharmaceutical compositions containing a chelating agent
11/02/2000EP1047395A1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative
11/02/2000CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
11/02/2000CA2370895A1 Miotic agents and hypertonic agents containing ophthalmic compositions
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2369109A1 Thrombin inhibitors
11/01/2000CN1272063A Prostaglandin product
11/01/2000CN1271588A Medicine for treating myopia
10/2000
10/31/2000US6140356 Opthalmic pharmaceutical compositions comprising a nitrone compound and methods for treating ocular inflammation using such compositions
10/31/2000US6140344 For treating pathological conditions such as asthma, rhinitis, eczema and parasitic infections featuring tissue eosinophilia
10/31/2000US6140335 Use of mizolastine for treating inflammatory diseases associated with 5-lipoxygenase
10/31/2000US6138680 Method for destroying retinal pigment epithelial cells
10/27/2000CA2307108A1 Process for production of mammalian cell lines, produced cell lines and their uses
10/26/2000WO2000063702A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000WO2000063430A1 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000063222A2 Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
10/26/2000WO2000063204A2 Substituted azoles
10/26/2000WO2000063191A1 Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
10/26/2000WO2000063181A1 Use of maduraphthalazine derivatives as inhibitors of pro-inflammatory cytokins
10/26/2000WO2000063178A1 Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis
10/26/2000WO2000063166A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
10/26/2000WO2000063165A1 Mmp inhibitor
10/26/2000WO2000063148A1 Salts of asiatic and madecassic acid suitable for the preparation of pharmaceutical and cosmetic compositions
10/26/2000WO2000062797A1 Remedies for autonomic neuropathy
10/26/2000WO2000062778A1 Cyclic protein tyrosine kinase inhibitors
10/26/2000WO2000062769A2 Use of ap-1 activators to treat glaucoma and ocular hypertension
10/26/2000WO2000062766A2 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/26/2000WO2000039120A3 Compounds and methods for modulation of estrogen receptors
10/26/2000WO2000037646A3 Group b streptococcus proteins, and their use
10/26/2000WO2000037099A3 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor
10/26/2000WO2000035477A3 Multi-component vaccine comprising at least two antigens from haemophilus influenzae
10/26/2000WO2000018230A9 Combination of bisphosphonate and tetracycline
10/26/2000WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
10/26/2000WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
10/26/2000WO2000006206A9 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/26/2000DE19918324A1 Bactericidal, virucidal, fungicidal and antiprotozoal pharmaceutical composition, especially for ophthalmological use, contains benzalkonium salt
10/26/2000CA2370713A1 Salts of asiatic and madecassic acid suitable for the preparation of pharmaceutical and cosmetic compositions
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2370127A1 Novel method of treatment
10/26/2000CA2369126A1 Use of ap-1 activators to treat glaucoma and ocular hypertension
10/26/2000CA2367359A1 Dibenzoazulene derivatives for the treatment of thrombosis, osteoporosis, arteriosclerosis
10/26/2000CA2363994A1 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy
10/26/2000CA2363945A1 Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
10/25/2000EP1045850A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
10/25/2000EP1045849A1 Purine derivatives having phosphodiesterase iv inhibition activity
10/25/2000EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
10/25/2000CN1271288A Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
10/25/2000CN1270959A 4-phenyl pyridine derivatives
10/25/2000CN1270838A Adjuvant used in vaccine
10/25/2000CN1057772C Compounds and compositions for treatment of immunomediated inflammatory disorders
10/25/2000CN1057686C Powder medicine for otitis
10/24/2000US6136974 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
10/24/2000US6136861 Bicyclo[2.2.1]heptanes and related compounds
10/24/2000US6136859 Mixture of selenmethionine, carotene, ascorbic acid, tocopherol, methionine and coenzyme q10 in a carrier
10/24/2000US6136850 Methods and compositions for inhibiting deposit formation on contact lenses
10/24/2000US6136848 Antiallergens; asthma therapy
10/24/2000US6136839 Using a sulfone or sulfoamide benzene compound
10/24/2000CA2157247C Physical form of dihydro-2,3-benzodiazepine derivative
10/24/2000CA2021316C Intraocular pressure reducing 11-acyl prostaglandins
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061754A2 Human proteins and polynucleotides encoding them
1 ... 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 ... 531